Guardion Health Sciences, Inc. (GHSI)
- Previous Close
8.07 - Open
7.85 - Bid --
- Ask --
- Day's Range
7.79 - 8.07 - 52 Week Range
5.01 - 10.75 - Volume
7,484 - Avg. Volume
221,782 - Market Cap (intraday)
10.248M - Beta (5Y Monthly) 0.88
- PE Ratio (TTM)
66.50 - EPS (TTM)
0.12 - Earnings Date May 13, 2024 - May 17, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
40.00
Guardion Health Sciences, Inc., a clinical nutrition company, develops and distributes clinically supported dietary supplements and medical foods in North America, Europe, and internationally. The company offers GlaucoCetin, a dietary supplement to support mitochondrial function with additional antioxidants to help reduce oxidative stress and increase blood flow throughout the body for enhanced eye support and ocular health; and Lumega-Z, a medical food that replenishes and restores the macular protective pigment. It also provides Viactiv Omega Boost Gel Bites, an omega-3 fish oil dietary supplement. The company distributes medical foods products through e-commerce website, guardionhealth.com. Guardion Health Sciences, Inc. was founded in 2009 and is headquartered in Houston, California.
www.guardionhealth.com9
Full Time Employees
December 31
Fiscal Year Ends
Sector
Recent News: GHSI
Performance Overview: GHSI
Trailing total returns as of 4/24/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: GHSI
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: GHSI
Valuation Measures
Market Cap
10.25M
Enterprise Value
4.85M
Trailing P/E
66.50
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.83
Price/Book (mrq)
1.26
Enterprise Value/Revenue
0.40
Enterprise Value/EBITDA
-1.24
Financial Highlights
Profitability and Income Statement
Profit Margin
1.29%
Return on Assets (ttm)
-14.66%
Return on Equity (ttm)
1.48%
Revenue (ttm)
12.25M
Net Income Avi to Common (ttm)
158.03k
Diluted EPS (ttm)
0.12
Balance Sheet and Cash Flow
Total Cash (mrq)
6.36M
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
331.92k